FindTrial
Sign In

Effect of transdermal microneedle patch with NSAID in osteoarthritic Knee

Effect of Transdermal microneedle patch with NSAID in osteoarthritic Knee

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200613001
Enrollment
Unknown
Registered
2020-06-13
Start date
2020-04-22
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Osteoarthritic knee Kallgren&#45

Interventions

Transdermal microneedle patch with Ketorolac 1ml(30mg/ml),Transdermal microneedle patch
Experimental Drug,Placebo Comparator No treatment
Transdermal microneedle patch with NSAID,Transdermal microneedle patch

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients with primary osteoarthritic knee Kallgren-Lawrence classification I-II.

Exclusion criteria

Exclusion criteria: patient with inflammatory arthritis, septic arthritis, skin infection, liver and renal insufficiency. patient who underwent intra-articular hyaluronic acid within 6months and steroid injection within 3months.

Design outcomes

Primary

MeasureTime frame
knee synovial thickness 0, 1, 2, 4 weeks millimeter—

Secondary

MeasureTime frame
knee pain 0, 1, 2, 4 weeks VAS score,WOMAC 0, 1, 2, 4 weeks modified Thai WOMAC score—

Countries

ไทย

Contacts

Public ContactMongkon pisuttanawat

Hip and Knee Fellowship

mk_ping@hotmail.co.th6625955858

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026